# Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation

> **NCT00336531** · PHASE4 · COMPLETED · sponsor: **Samsung Medical Center** · enrollment: 100 (estimated)

## Conditions studied

- Neuroblastoma
- Brain Tumor
- Retinoblastoma
- Wilms Tumor
- Mycoses

## Interventions

- **DRUG:** itraconazole

## Key facts

- **NCT ID:** NCT00336531
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2008-06
- **Final completion:** 2008-10
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2008-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00336531

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00336531, "Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00336531. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*